A review of mass spectrometry‐based analyses to understand COVID‐19 convalescent plasma mechanisms of action von Baros‐Steyl, Seanantha S., Al Heialy, Saba, Semreen, Ahlam H., Semreen, Mohammad H., Blackburn, Jonathan M., Soares, Nelson C.

Volltext

Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research von Ahmed, Munazza, Semreen, Ahlam M, El-Huneidi, Waseem, Bustanji, Yasser, Abu-Gharbieh, Eman, Alqudah, Mohammad A Y, Alhusban, Ahmed, Shara, Mohd, Abuhelwa, Ahmad Y, Soares, Nelson C, Semreen, Mohammad H, Alzoubi, Karem H

Volltext

Evaluation of imidazo[2,1–b]thiazole-based anticancer agents in one decade (2011–2020): Current status and future prospects von Sbenati, Rawan M., Semreen, Mohammad H., Semreen, Ahlam M., Shehata, Mahmoud K., Alsaghir, Fai M., El-Gamal, Mohammed I.

Volltext

Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel von Ahmed, Munazza, Semreen, Ahlam M, Giddey, Alexander D, Ramadan, Wafaa S, El-Awady, Raafat, Soares, Nelson C, El-Huneidi, Waseem, Bustanji, Yasser, Alqudah, Mohammad A Y, Alzoubi, Karem H, Semreen, Mohammad H

Volltext

Multi-omics analysis revealed significant metabolic changes in brain cancer cells treated with paclitaxel and/or topotecan von Semreen, Ahlam M., Alsoud, Leen Oyoun, Semreen, Mohammad H., Ahmed, Munazza, Al-Hroub, Hamza M., El-Awady, Raafat, Ramadan, Wafaa S., Abuhelwa, Ahmad, Bustanji, Yasser, Soares, Nelson C., Alzoubi, Karem H.

Volltext

Metabolomics Analysis Revealed Significant Metabolic Changes in Brain Cancer Cells Treated with Paclitaxel and/or Etoposide von Semreen, Ahlam M, Alsoud, Leen Oyoun, El-Huneidi, Waseem, Ahmed, Munazza, Bustanji, Yasser, Abu-Gharbieh, Eman, El-Awady, Raafat, Ramadan, Wafaa S, Alqudah, Mohammad A Y, Shara, Mohd, Abuhelwa, Ahmad Y, Soares, Nelson C, Semreen, Mohammad H, Alzoubi, Karem H

Volltext